Biblio

Author Title [ Type

] Year

Filters: Author is Jurdi, Najla El [Clear All Filters]

Journal Article

Jurdi NEl, Filali-Mouhim A, Salem I, Retuerto M, Dambrosio NMargaret, Baer L, Lazarus HM, Caimi P, Cooper B, Tomlinson B, et al. Gastrointestinal Microbiome and Mycobiome changes during Autologous Transplantation for Multiple Myeloma: Results of a Prospective Pilot Study. Biol Blood Marrow Transplant. 2019.

Jurdi NEl, Martens MJ, Brunstein CG, O'Donnell P, Lee SJ, D'Souza A, Logan B, Hong S, Singh AK, Sandhu K, et al. Heath-related Quality of Life in Double Umbilical Cord Blood vs. Haploidentical Marrow Transplantation: a QOL Analysis Report of BMT CTN 1101. Transplant Cell Ther. 2023.

Merino A, Shanley R, Rashid F, Langer J, Dolan M, Tu S, Jurdi NEl, Rogosheske J, Hanna K, DeFor T, et al. Impact of melphalan day -1 vs day -2 on outcomes after autologous stem cell transplant for multiple myeloma. Front Immunol. 2024;15:1310752.

Sumransub N, Cao Q, Juckett M, Betts B, Holtan S, Jurdi NEl, Hu M, Allred J, Assi R, Maakaron JE. Sarcopenia Predicts Inferior Progression Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2023.

Herzog S, Shanley R, Holtan SG, MacMillan ML, Weisdorf DJ, Jurdi NEl. Treatment responsive acute GVHD after posttransplant cyclophosphamide-based prophylaxis: incidence and clinical outcomes. Transplant Cell Ther. 2024.